These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 24525080)
1. An observational study of matrix metalloproteinase (MMP)-9 in cystic fibrosis. Devereux G; Steele S; Jagelman T; Fielding S; Muirhead R; Brady J; Grierson C; Brooker R; Winter J; Fardon T; McCormick J; Huang JT; Miller D J Cyst Fibros; 2014 Sep; 13(5):557-63. PubMed ID: 24525080 [TBL] [Abstract][Full Text] [Related]
2. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis. Sagel SD; Kapsner RK; Osberg I Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615 [TBL] [Abstract][Full Text] [Related]
3. Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis. Delacourt C; Le Bourgeois M; D'Ortho MP; Doit C; Scheinmann P; Navarro J; Harf A; Hartmann DJ; Lafuma C Am J Respir Crit Care Med; 1995 Aug; 152(2):765-74. PubMed ID: 7633740 [TBL] [Abstract][Full Text] [Related]
4. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation]. Xin XF; Zhao M; Li ZL; Song Y; Shi Y Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998 [TBL] [Abstract][Full Text] [Related]
5. Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma. Chaudhuri R; McSharry C; Brady J; Grierson C; Messow CM; Spears M; Miele G; Nocka K; MacNee W; Connell M; Murchison JT; Sproule M; Hilmi OJ; Miller DK; Thomson NC Eur Respir J; 2014 Oct; 44(4):895-904. PubMed ID: 24993912 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function. Kosmala W; Plaksej R; Przewlocka-Kosmala M; Kuliczkowska-Plaksej J; Bednarek-Tupikowska G; Mazurek W Int J Obes (Lond); 2008 May; 32(5):763-71. PubMed ID: 18197181 [TBL] [Abstract][Full Text] [Related]
10. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Vignola AM; Riccobono L; Mirabella A; Profita M; Chanez P; Bellia V; Mautino G; D'accardi P; Bousquet J; Bonsignore G Am J Respir Crit Care Med; 1998 Dec; 158(6):1945-50. PubMed ID: 9847290 [TBL] [Abstract][Full Text] [Related]
11. Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction. Jackson PL; Xu X; Wilson L; Weathington NM; Clancy JP; Blalock JE; Gaggar A Mol Med; 2010; 16(5-6):159-66. PubMed ID: 20111696 [TBL] [Abstract][Full Text] [Related]
12. MMP-7 and TIMP-1, new targets in predicting poor wound healing in apical periodontitis. Letra A; Ghaneh G; Zhao M; Ray H; Francisconi CF; Garlet GP; Silva RM J Endod; 2013 Sep; 39(9):1141-6. PubMed ID: 23953287 [TBL] [Abstract][Full Text] [Related]
13. [Serum and urinary concentration of selected metalloproteinases and their tissue inhibitors in children with vesicoureteral reflux]. Taranta-Janusz K; Zoch-Zwierz W; Wasilewska A; Tenderenda E; Korzeniecka-Kozerska A Pol Merkur Lekarski; 2010 Aug; 29(170):88-92. PubMed ID: 20842819 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis. Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734 [TBL] [Abstract][Full Text] [Related]
15. Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients: relation to tumor necrosis factor-alpha and interleukin-10. Beeh KM; Beier J; Kornmann O; Micke P; Buhl R J Heart Lung Transplant; 2001 Nov; 20(11):1144-51. PubMed ID: 11704473 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. Gaggar A; Li Y; Weathington N; Winkler M; Kong M; Jackson P; Blalock JE; Clancy JP Am J Physiol Lung Cell Mol Physiol; 2007 Jul; 293(1):L96-L104. PubMed ID: 17384080 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis. Taylor SL; Rogers GB; Chen AC; Burr LD; McGuckin MA; Serisier DJ Ann Am Thorac Soc; 2015 May; 12(5):701-7. PubMed ID: 25679336 [TBL] [Abstract][Full Text] [Related]
18. TIMP-1/-2 and transient elastography allow non invasive diagnosis of cystic fibrosis associated liver disease. Rath T; Menendez KM; Kügler M; Hage L; Wenzel C; Schulz R; Graf J; Nährlich L; Roeb E; Roderfeld M Dig Liver Dis; 2012 Sep; 44(9):780-7. PubMed ID: 22652148 [TBL] [Abstract][Full Text] [Related]
19. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Beeh KM; Beier J; Kornmann O; Buhl R Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147 [TBL] [Abstract][Full Text] [Related]
20. Environmental arsenic exposure and sputum metalloproteinase concentrations. Josyula AB; Poplin GS; Kurzius-Spencer M; McClellen HE; Kopplin MJ; Stürup S; Clark Lantz R; Burgess JL Environ Res; 2006 Nov; 102(3):283-90. PubMed ID: 16487958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]